Regenerx Biopharma buy melinda
Start price
01.11.10
/
50%
€0.13
Target price
02.05.11
€0.20
Performance (%)
-17.32%
End price
02.05.11
€0.11
Summary
This prediction ended on 02.05.11 with a price of €0.11. The prediction for Regenerx Biopharma disappointed with a performance of -17.32%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Regenerx Biopharma | - | - | - | - |
iShares Core DAX® | 1.518% | 3.456% | 25.970% | 21.597% |
iShares Nasdaq 100 | 1.240% | 2.983% | 31.325% | 39.177% |
iShares Nikkei 225® | 2.808% | 2.743% | 19.597% | 5.115% |
iShares S&P 500 | 0.403% | 2.187% | 28.624% | 40.348% |
Comments by melinda for this prediction
In the thread Regenerx Biopharma diskutieren
Biopharma-
regernerx Biopharma hat die Rechte der NIH, dass das Unternehmen seine Aufmerksamkeit auf ProtectOn und die Reparatur von Gewebe konzentrieren können erworben
(Laufzeit überschritten)